Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma

Cancer Immunology, Immunotherapy

Volumn 58, Issue 7, 2009, Pages 1085-1094

  Johansson, C Christian ^a   Egyházi, Suzanne ^a   Masucci, Giuseppe ^a   Harlin, Helena ^a   Mougiakakos, Dimitrios ^a   Poschke, Isabel ^a   Nilsson, Bo ^a   Garberg, Liss ^a   Tuominen, Rainer ^a   Linden, Diana ^a   Stolt, Marianne Frostvik ^a   Hansson, Johan ^a   Kiessling, Rolf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

COX 2; INOS; Metastatic lymph node; Prognostic factor; Stage III melanoma; Survival

Indexed keywords

B RAF KINASE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MELANOMA; MUTATION RATE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SKIN ULCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NITRIC OXIDE SYNTHASE TYPE II; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS;

EID: 67349105613     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0631-1     Document Type: Article

References (43)

1. LA Akslen S Angelini O Straume IM Bachmann A Molven K Hemminki R Kumar 2005 BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival J Invest Dermatol 125 312 317 (Pubitemid 41648165)
2. CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit ID Fleming JE Gershenwald A Houghton Jr JM Kirkwood KM [tmp] McMasters MF Mihm DL Morton DS Reintgen MI Ross A Sober JA Thompson JF(ed) Thompson 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 (Pubitemid 32786276)
3. CM Balch SJ Soong JE Gershenwald JF Thompson DS Reintgen N Cascinelli M Urist KM [tmp] McMasters MI Ross JM Kirkwood MB Atkins JA Thompson DG Coit D Byrd R Desmond Y Zhang PY Liu GH Lyman A Morabito 2001 Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622 3634 (Pubitemid 32786275)
4. F Bianchini D Massi C Marconi A Franchi G Baroni M Santucci A Mannini G Mugnai L Calorini 2007 Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression Prostaglandins Other Lipid Mediat 83 320 328 (Pubitemid 46710469)
5. C Bogdan M Rollinghoff A Diefenbach 2000 The role of nitric oxide in innate immunity Immunol Rev 173 17 26 (Pubitemid 30095207)
6. V Bronte P Serafini A Mazzoni DM Segal P Zanovello 2003 l-arginine metabolism in myeloid cells controls T-lymphocyte functions Trends Immunol 24 302 306 (Pubitemid 36694880)
7. Y Chudnovsky AE Adams PB Robbins Q Lin PA Khavari 2005 Use of human tissue to assess the oncogenic activity of melanoma-associated mutations Nat Genet 37 745 749 (Pubitemid 41754892)
8. BW Chwirot L Kuzbicki 2007 Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours Melanoma Res 17 139 145 (Pubitemid 46788098)
9. F Cianchi C Cortesini O Fantappie L Messerini I Sardi N Lasagna F Perna V Fabbroni A Di Felice G Perigli R Mazzanti E Masini 2004 Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin Cancer Res 10 2694 2704 (Pubitemid 38509144)
10. R Clancy B Varenika W Huang L Ballou M Attur AR Amin SB Abramson 2000 Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production J Immunol 165 1582 1587 (Pubitemid 30604595)
11. JA Curtin J Fridlyand T Kageshita HN Patel KJ Busam H Kutzner KH Cho S Aiba EB Bröcker PE LeBoit D Pinkel BC Bastian 2005 Distinct sets of genetic alterations in melanoma N Engl J Med 353 2135 2147 (Pubitemid 41653105)
12. H Davies GR Bignell C Cox P Stephens S Edkins S Clegg J Teague H Woffendin MJ Garnett W Bottomley N Davis E Dicks R Ewing Y Floyd K Gray S Hall R Hawes J Hughes V Kosmidou A Menzies C Mould A Parker C Stevens S Watt S Hooper R Wilson H Jayatilake BA Gusterson C Cooper J Shipley D Hargrave K Pritchard-Jones N Maitland G Chenevix-Trench GJ Riggins DD Bigner G Palmieri A Cossu A Flanagan A Nicholson JW Ho SY Leung ST Yuen BL Weber HF Seigler TL Darrow H Paterson R Marais CJ Marshall R Wooster MR Stratton PA Futreal 2002 Mutations of the BRAF gene in human cancer Nature 417 949 954 (Pubitemid 34716871)
13. C Denkert M Kobel S Berger A Siegert A Leclere U Trefzer S Hauptmann 2001 Expression of cyclooxygenase 2 in human malignant melanoma Cancer Res 61 303 308 (Pubitemid 32095731)
14. SM Dubinett S Sharma M Huang M Dohadwala M Pold JT Mao 2003 Cyclooxygenase-2 in lung cancer Prog Exp Tumor Res 37 138 162 (Pubitemid 36767984)
15. RN Dubois SB Abramson L Crofford RA Gupta LS Simon LB Van De Putte PE Lipsky 1998 Cyclooxygenase in biology and disease FASEB J 12 1063 1073 (Pubitemid 28418937)
16. RN Dubois A Radhika BS Reddy AJ Entingh 1996 Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 110 1259 1262 (Pubitemid 26113767)
17. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 (Pubitemid 24294584)
18. S Ekmekcioglu JA Ellerhorst VG Prieto MM Johnson LD Broemeling EA Grimm 2006 Tumor iNOS predicts poor survival for stage III melanoma patients Int J Cancer 119 861 866 (Pubitemid 44051450)
19. S Ekmekcioglu J Ellerhorst CM Smid VG Prieto M Munsell AC Buzaid EA Grimm 2000 Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival Clin Cancer Res 6 4768 4775 (Pubitemid 32110418)
20. JA Ellerhorst S Ekmekcioglu MK Johnson CP Cooke MM Johnson EA Grimm 2006 Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma Oncogene 25 3956 3962 (Pubitemid 43990751)
21. VC Gray-Schopfer S a Dias R Marais 2004 The role of B-RAF in melanoma Cancer Metastasis Rev 24 165 183 (Pubitemid 40576070)
22. JB Hibbs Jr 1991 Synthesis of nitric oxide from l-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity Res Immunol 142 565 569 discussion 96-8
23. JB Hibbs Jr RR Taintor Z Vavrin EM Rachlin 1988 Nitric oxide: a cytotoxic activated macrophage effector molecule Biochem Biophys Res Commun 157 87 94 (Pubitemid 19004828)
24. LJ Ignarro GM Buga KS Wood RE Byrns G Chaudhuri 1987 Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci USA 84 9265 9269
25. M Jaiswal NF LaRusso LJ Burgart GJ Gores 2000 Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 184 190 (Pubitemid 30058750)
26. R Kumar S Angelini K Hemminki 2003 Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9 Oncogene 22 9217 9224 (Pubitemid 38122033)
27. D Massi A Franchi I Sardi L Magnelli M Paglierani L Borgognoni U Maria Reali M Santucci 2001 Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions J Pathol 194 194 200 (Pubitemid 32519969)
28. C Michaloglou LC Vredeveld MS Soengas C Denoyelle T Kuilman CM van der Horst DM Majoor JW Shay WJ Mooi DS Peeper 2005 BRAFE600-associated senescence-like cell cycle arrest of human naevi Nature 436 720 724 (Pubitemid 41117276)
29. MA Molina M Sitja-Arnau MG Lemoine ML Frazier FA Sinicrope 1999 Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59 4356 4362 (Pubitemid 29418754)
30. T Ostendorf C Van Roeyen R Westenfeld A Gawlik M Kitahara E De Heer D Kerjaschki J Floege M Ketteler 2004 Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors J Am Soc Nephrol 15 2307 2319 (Pubitemid 39159331)
31. P Patrignani S Tacconelli MG Sciulli ML Capone 2005 New insights into COX-2 biology and inhibition Brain Res Brain Res Rev 48 352 359 (Pubitemid 40585766)
32. CV Rao 2004 Nitric oxide signaling in colon cancer chemoprevention Mutat Res 555 107 119 (Pubitemid 39345400)
33. PC Rodriguez DG Quiceno J Zabaleta B Ortiz AH Zea MB Piazuelo A Delgado P Correa J Brayer EM Sotomayor S Antonia JB Ochoa AC Ochoa 2004 Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses Cancer Res 64 5839 5849 (Pubitemid 39095585)
34. DL Rousseau Jr JE Gershenwald 2004 The new staging system for cutaneous melanoma in the era of lymphatic mapping Semin Oncol 31 415 425 (Pubitemid 38869520)
35. O Salvucci M Carsana I Bersani G Tragni A Anichini 2001 Antiapoptotic role of endogenous nitric oxide in human melanoma cells Cancer Res 61 318 326 (Pubitemid 32095733)
36. K Satyamoorthy G Li PA Van Belle DE Elder M Herlyn 2002 A versatile method for the removal of melanin from ribonucleic acids in melanocytic cells Melanoma Res 12 449 452 (Pubitemid 35264721)
37. M Sensi G Nicolini C Petti I Bersani F Lozupone A Molla C Vegetti D Nonaka R Mortarini G Parmiani S Fais A Anichini 2006 Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma Oncogene 25 3357 3364 (Pubitemid 43877040)
38. CH Tang EA Grimm 2004 Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines J Biol Chem 279 288 298 (Pubitemid 38044827)
39. LL Thomsen DW Miles L Happerfield LG Bobrow RG Knowles S Moncada 1995 Nitric oxide synthase activity in human breast cancer Br J Cancer 72 41 44
40. LL Thomsen FG Lawton RG Knowles JE Beesley V Riveros-Moreno S Moncada 1994 Nitric oxide synthase activity in human gynecological cancer Cancer Res 54 1352 1354 (Pubitemid 24108080)
41. K Uefuji T Ichikura H Mochizuki N Shinomiya 1998 Expression of cyclooxygenase-2 protein in gastric adenocarcinoma J Surg Oncol 69 168 172 (Pubitemid 28549893)
42. D Wang RN Dubois 2006 Prostaglandins and cancer Gut 55 115 122 (Pubitemid 41820645)
43. C Wellbrock L Ogilvie D Hedley M Karasarides J Martin D Niculescu-Duvaz CJ Springer R Marais 2004 V599 EB-RAF is an oncogene in melanocytes Cancer Res 64 2338 2342